2.0.97
2023-06-06
June 2023
(monthly update)
Modifications to RxVigilance
=========================
Colonoscopy preparation in patients with diabetes
We have added a section on the management of diabetes medications to our chart of common bowel preparation agents for colonoscopy.
New monograph
=========================
Ubrogepant (Ubrelvy)
Lenacapavir (Sunlenca)
Spesolimab (Spevigo)
2.0.96
2023-05-01
May 2023
(monthly update)
Modifications to RxVigilance
=========================
Parenteral Administration Guide
We have redesigned our parenteral administration sheets. They are still filled with useful information, but they are now more streamlined and user-friendly.
You'll find information on storage, reconstitution, stability, indications, and doses according to the administration routes of the drug concerned.
New monograph
=========================
Tirzepatide (Mounjaro)
Mometasone furoate nasal + olopatadine nasal (Ryaltris)
Deucravacitinib (Sotyktu)
Pegcetacoplan (Empaveli)
Belumosudil (Rezurock)
2.0.95
2023-04-01
April 2023 (monthly update)
New monograph
=========================
Norethindrone (NORLUTATE)
2.0.94
2023-03-10
March 2023 (monthly update)
New monographs
=========================
Mavacamten (CAMZYOS)
Atogepant (QULIPTA)
2.0.93
2023-02-07
February 2023 (monthly update)
Modification to RxVigilance
=========================
Hormonal contraception and adverse effects
Although the adverse effects of hormonal contraception usually disappear during the second or third month of use, they are the main reason for discontinuing treatment.
To help you with users of hormonal birth control, we have updated our chart on managing the adverse effects of hormonal contraceptives.
2.0.92
2023-01-10
January 2023 (monthly update)
Modifications to RxVigilance
=========================
Hormonal contraception and adverse effects
Although the adverse effects of hormonal contraception usually disappear during the second or third month of use, they are the main reason for discontinuing treatment.
To help you with users of hormonal birth control, we have updated our chart on managing the adverse effects of hormonal contraceptives.
New monograph
=========================
Finerenone (Kerendia)
Selumetinib (Koselugo)
Difelikefalin (Korsuva)
Maribavir (Livtencity)
2.0.91
2022-11-30
December 2022 (monthly update)
Modifications to RxVigilance
=========================
Laxatives and stool softeners in pediatrics
The pediatric section of our laxative and stool softener comparison table has been updated and now contains a wealth of information on the subject. Among other things, it covers diagnosis, warning signs to watch out for, and pharmacological treatments.
New monograph
=========================
Capmatinib (Tabrecta)
2.0.90
2022-10-28
November 2022 (monthly update)
Modifications to RxVigilance
=========================
Grapefruit interactions
Our team has updated the list of drugs that may interact with grapefruit. This information is available in the Food and Interactions sections of our product monographs for all concerned drugs. A professional document is also available.
New monographs
=========================
Belzutifan (Welireg)
Berotralstat (Orladeyo)
Pegvaliase (Palynziq)
Tezepelumab (Tezspire)
2.0.89
2022-10-20
October 2022 (monthly update)
Modifications to RxVigilance
=========================
Secondary prevention of cardiovascular diseases
The information on secondary prevention of cardiovascular diseases has been updated and is now included in our comparative drug chart for oral antiplatelet agents. This table presents some of the antiplatelet regimens used in the management of certain events related to coronary heart disease.
New monographs
=========================
Abrocitinib (Cibinqo)
Avacopan (Tavneos)
2.0.88
2022-10-18
October 2022 (monthly update)
Modifications to RxVigilance
=========================
Secondary prevention of cardiovascular diseases
The information on secondary prevention of cardiovascular diseases has been updated and is now included in our comparative drug chart for oral antiplatelet agents. This table presents some of the antiplatelet regimens used in the management of certain events related to coronary heart disease.
New monographs
=========================
Abrocitinib (Cibinqo)
Avacopan (Tavneos)
2.0.87
2022-10-05
October 2022 (monthly update)
Modifications to RxVigilance
=========================
Secondary prevention of cardiovascular diseases
The information on secondary prevention of cardiovascular diseases has been updated and is now included in our comparative drug chart for oral antiplatelet agents. This table presents some of the antiplatelet regimens used in the management of certain events related to coronary heart disease.
New monographs
=========================
Abrocitinib (Cibinqo)
Avacopan (Tavneos)
2.0.86
2022-08-31
September 2022 (monthly update)
New monographs
=========================
Asciminib (Scemblix)
Selinexor (Xpovio)
Sodium phenylbutyrate + ursodoxicoltaurine (Albrioza)
2.0.85
2022-08-05
August 2022 (monthly update)
New monographs
=========================
Faricimab (Vabysmo)
2.0.84
2022-06-30
July 2022 (monthly update)
Modifications to RxVigilance
=========================
Monographs
Two new product monographs related to smallpox and monkeypox are available. The first is related to the smallpox and monkeypox vaccine (orthopoxvirus-vaccine), and the second is about tecovirimat.
New monographs
=========================
Cariprazine (Vraylar)
Orthopoxvirus-vaccine (Imvamune)
Prasterone vaginal (Intrarosa)
Tecovirimat (Tpoxx)
2.0.83
2022-06-04
June 2022 (monthly update)
Modifications to RxVigilance
=========================
New natural products fact sheets
We have added 3 new natural health product sheets: apple cider vinegar, quercetin and peppermint. Among other things, they contain information about common uses, side effects to look out for, warnings, and potential interactions. Depending on your RxVigilance subscription, separate sheets for professionals and patients are available.
You can access them via the Natural Products index at the bottom of the homepage.
New monographs
=========================
Dequalinium (Vablys)
Tixagevimab + cilgavimab (Evusheld)
Drospirerone (Slynd)
2.0.82
2022-05-04
May 2022 (monthly update)
Modifications to RxVigilance
=========================
Common Bowel Preparation Agents for Colonoscopy
The comparative chart on common bowel preparation agents for colonoscopy has been updated. It can be used to compare options and assist with medication management in preparation for colonoscopy, among other things.
New monographs
=========================
Fostemsavir (Rukobia)
Cenegermin (Oxervate)
Lumasiran (Oxlumo)
Bimekizumab (Bimzelx)
2.0.81
2022-03-31
April 2022 (monthly update)
Modifications to RxVigilance
=========================
Menopausal therapy
We have updated our data in order to incorporate the new SOGC clinical guidelines for the treatment of menopausal symptoms. Accordingly, our menopausal hormone therapy comparative chart and some of our monographs have been updated.
New monographs
=========================
Selpercatinib (Retevmo)
Avalglucosidase alfa (Nexviazyme)
Somatrogon (Ngenla)
2.0.80
2022-03-05
March 2022 (monthly update)
Modifications to RxVigilance
=========================
Vaginal moisturizers and lubricants
We have created a brand-new chart for vaginal moisturizers and lubricants. This chart contains useful information to help you advise your patients in choosing products to treat vaginal dryness. It outlines the features and drawbacks of the various products on the market, their compatibility with condoms, and more.
New monographs
=========================
Anifrolumab (Saphnelo)
Nirmatrelvir + ritonavir (Paxlovid)
Pitolisant (Wakix)
2.0.79
2022-02-10
February 2022 (monthly update)
Modifications to RxVigilance
=========================
Commercial infant formulas
The comparative chart of commercial infant formulas has been updated. It can be used to find comparable products based on their contents and help you choose a formula that meets the infant's needs. We have also added a comparison chart of various human milk fortifiers.
New monographs
=========================
Tralokinumab (Adtralza)
Tadalafil + macitentan (Opsynvi)
Glycopyrronium + formoterol + budesonide (Breztri)
2.0.78
2022-01-04
January 2022 (monthly update)
Modifications to RxVigilance
=========================
Natural products fact sheets - Natural Products
Our natural product fact sheets now feature new content and visuals. Among other things, they contain information about common uses, side effects to look out for, warnings, and potential interactions. Depending on your RxVigilance subscription, separate sheets for professionals and patients are now available.
You can access them via the Search field or the Natural Products index at the bottom of the homepage.
New monographs
=========================
Plecanatide (Trulance)
Tepotinib (Tepmetko)
Ospemifene (Osphena)
Ponesimod (Ponvory)
2.0.77
2021-11-27
December 2021
(monthly update)
Modifications to RxVigilance
=========================
Migraines - Comparative Drug Charts
We've created a brand-new document explaining the medications used to treat migraines. It includes comparative data on various migraine medications, as well as information regarding migraine types and treatment options.
New monographs
=========================
Pemigatinib (Pemazyre)
Sotorasib (Lumakras)
2.0.76
2021-11-02
November(monthly update)
Modifications to RxVigilance
=========================
A new section on Pharmacogenomics is now available in our monographs!
Located under Indications and dosages, it presents data from the CPIC (Clinical Pharmacogenetics Implementation Consortium).
New monographs
=========================
Chlormethine topical (Ledaga)
Ravulizumab (Ultomiris)
2.0.75
2021-10-04
October 2021
(monthly update)
Modifications to RxVigilance
=========================
A new section on Pharmacogenomics is now available in our monographs!
Located under Indications and dosages, it presents data from the CPIC (Clinical Pharmacogenetics Implementation Consortium).
New monographs
=========================
Sotrovimab
Inclisiran (Leqvio)
Tildrakizumab (Ilumya)
2.0.74
2021-08-28
September 2021
(monthly update)
New monographs
=========================
Binimetinib (Mektovi)
Encorafenib (Braftovi)
Ivacaftor + tezacaftor + elexacaftor (Trikafta)
Pralsetinib (Gavreto)
Solriamfetol (Sunosi)
2.0.73
2021-07-31
August 2021
(monthly update)
New monographs
=========================
Vancomycin-injectable (Vancocin IV)
Casirivimab + imdevimab
Dalbavancin (Xydalba)
Fedratinib (Inrebic)